Use the benefits of AI in your sector and generate a transformation with maximum value
Discover Aitenea
The world is changing. Do you share our view?
“AI has the ability to transform traditional models”
Our working, prediction and synthesis system hits on problems relevant to society, such as the creation of molecules, the effective development of new drugs, the reduction of greenhouse gas, new energies and cleaner fuels, sustainable agriculture, a better diagnosis and personalised treatment of diseases…
It accelerates research cycles and improves productivity
More sustainable solutions
A responsible AI benefits users, communities and society
It increases success and efficiency rates
”We always overestimate the change that will occur in the next two years and underestimate the change that will occur in the next 10
Bill Gates
We apply AI techniques to identify pharmacological goals for the design and repositioning of drugs and the speeding-up of I+D processes
We develop prediction models that work on large databases and we synthesise molecules
We combine the benefits of AI and innovation to promote new scientific discoveries
We make available a platform physicochemical and pharmacological properties (toxicity, absorption, excretion, or efficiency) in any organic molecule
We offer our wide research experience, advanced analytical services and our molecular synthesis abilities so we help you find the best I+D strategy
A reduction of up to 50% of the time dedicated to the development of a new drug
Developing a new drug can take between 12 and 15 years, considering the usual timing and processes. However, if prediction and machine learning models are included through Artificial Intelligence (AI), that time can be reduced up to a 50%.
Our goal is to find smart solutions with a positive impact in society that will help tackle the main social issues and find new approaches based on technological innovation that will remove barriers towards an intelligent future.
Source: Tech Emergence Report 2019
Candidate development and preclinical stage
-45
26
Clinical trials
-55
28
Cost-saving associated with drug development with AI
The average cost of developing a new drug has increased —that increase is of a 70% from 2010 on
Source: Tech Emergence Report 2019
Collaborators:
Awards and recognitions:
Learn the value of AI for the industry
Contact us!
If you have further questions or you want to know more about Aitenea, send us an e-mail and we’ll answer it as soon as possible
